Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Reinvestment Rate
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Reinvestment Rate of 1.27x as of September 2025, reinvesting CN¥11.62 Million (capex CN¥11.62 Million ) from operating cash flow of CN¥9.12 Million. See cash generation quality of Shenzhen Bioeasy Biotechnology Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Shenzhen Bioeasy Biotechnology Co. Ltd. generate cash.
Annual Cash Flow Reinvestment Rate for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year capital reinvestment analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. See Shenzhen Bioeasy Biotechnology Co. Ltd. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥54.67 Million | CN¥66.87 Million | CN¥45.90 Million | ▼ -87.0% |
| 2024 | 6.28x | CN¥215.23 Million | CN¥34.26 Million | CN¥174.10 Million | ▲ +161.3% |
| 2022 | 2.40x | CN¥366.80 Million | CN¥152.55 Million | CN¥176.85 Million | ▲ +21.4% |
| 2021 | 1.98x | CN¥506.07 Million | CN¥255.42 Million | CN¥79.51 Million | ▼ -19.3% |
| 2020 | 2.46x | CN¥156.65 Million | CN¥63.79 Million | CN¥82.84 Million | ▲ +259.2% |
| 2019 | 0.68x | CN¥45.97 Million | CN¥67.24 Million | CN¥26.29 Million | ▲ +276.1% |
| 2018 | 0.18x | CN¥10.53 Million | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥10.82 Million | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥9.03 Million | CN¥36.31 Million | CN¥9.03 Million | — |